CN1712525A - 淀粉海藻糖基合成酶及其编码基因与表达方法和工程菌 - Google Patents
淀粉海藻糖基合成酶及其编码基因与表达方法和工程菌 Download PDFInfo
- Publication number
- CN1712525A CN1712525A CN 200410048075 CN200410048075A CN1712525A CN 1712525 A CN1712525 A CN 1712525A CN 200410048075 CN200410048075 CN 200410048075 CN 200410048075 A CN200410048075 A CN 200410048075A CN 1712525 A CN1712525 A CN 1712525A
- Authority
- CN
- China
- Prior art keywords
- starch
- mycose
- seq
- sequence
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000031888 Mycoses Diseases 0.000 title claims abstract description 66
- 229920002472 Starch Polymers 0.000 title claims abstract description 66
- 239000008107 starch Substances 0.000 title claims abstract description 66
- 235000019698 starch Nutrition 0.000 title claims abstract description 66
- 108090000364 Ligases Proteins 0.000 title claims abstract description 64
- 102000003960 Ligases Human genes 0.000 title claims abstract description 61
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 54
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 title abstract description 13
- 241000894006 Bacteria Species 0.000 claims abstract description 31
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims description 49
- 102000004190 Enzymes Human genes 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 38
- 241000588724 Escherichia coli Species 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 9
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 8
- 238000003259 recombinant expression Methods 0.000 claims description 7
- 210000001072 colon Anatomy 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 108091033319 polynucleotide Proteins 0.000 claims description 3
- 239000002157 polynucleotide Substances 0.000 claims description 3
- 102000040430 polynucleotide Human genes 0.000 claims description 3
- 230000008034 disappearance Effects 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 108020004414 DNA Proteins 0.000 description 23
- 239000007788 liquid Substances 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 244000005700 microbiome Species 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 10
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 9
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 9
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 9
- 238000001962 electrophoresis Methods 0.000 description 9
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000012216 screening Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000003636 conditioned culture medium Substances 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 102220023257 rs387907546 Human genes 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000186063 Arthrobacter Species 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 102220369447 c.1352G>A Human genes 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000002934 lysing effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108010046845 tryptones Proteins 0.000 description 3
- NLJVXZFCYKWXLH-DXTIXLATSA-N 3-[(3r,6s,9s,12s,15s,17s,20s,22r,25s,28s)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 NLJVXZFCYKWXLH-DXTIXLATSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 241000308162 Sulfolobus acidocaldarius DSM 639 Species 0.000 description 2
- 241000205091 Sulfolobus solfataricus Species 0.000 description 2
- 108010021006 Tyrothricin Proteins 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 102220369446 c.1274G>A Human genes 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- -1 proteolytic ferment Chemical compound 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 125000000647 trehalose group Chemical group 0.000 description 2
- 229960003281 tyrothricin Drugs 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108700005443 Microbial Genes Proteins 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000589187 Rhizobium sp. Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- 102220023258 rs387907548 Human genes 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
基因 | 开放阅读框架长度 | 氨基酸序列长度 | G+C(%) | 预测的分子量 |
G135基因 | 2199bp | 732 | 33.2 | 86kD |
菌株 | 海藻糖基合成酶活力(U/mL) |
大肠杆菌DE3(pM75)细胞上清液大肠杆菌DE3(pM75)培养上清液大肠杆菌DE3(pET)细胞上清液大肠杆菌DE3(pET)培养上清液 | 6.72.100 |
总酶活力(U) | 比活(U/mg) | 收率(%) | |
粗酶液热处理DEAE-Fast Flow离子柱层析Phenyl-Sepharose疏水柱层析Sephaeryl S-200凝胶柱层析 | 13.413.210.96.873.23 | 2.77.315.32255.7 | /99815124 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100480753A CN100393873C (zh) | 2004-06-14 | 2004-06-14 | 淀粉海藻糖基合成酶及其编码基因与表达方法和工程菌 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100480753A CN100393873C (zh) | 2004-06-14 | 2004-06-14 | 淀粉海藻糖基合成酶及其编码基因与表达方法和工程菌 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1712525A true CN1712525A (zh) | 2005-12-28 |
CN100393873C CN100393873C (zh) | 2008-06-11 |
Family
ID=35718320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100480753A Expired - Lifetime CN100393873C (zh) | 2004-06-14 | 2004-06-14 | 淀粉海藻糖基合成酶及其编码基因与表达方法和工程菌 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100393873C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110643552A (zh) * | 2019-11-22 | 2020-01-03 | 河南省科学院生物研究所有限责任公司 | 一种利用可溶性淀粉制备海藻糖浆的菌株及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151253C (zh) * | 2001-01-10 | 2004-05-26 | 中国科学院微生物研究所 | 海藻糖基水解酶及其制备和用途 |
CN1177043C (zh) * | 2001-07-27 | 2004-11-24 | 吴襟 | 嗜酸耐热海藻糖基合成酶及其制备和用途 |
-
2004
- 2004-06-14 CN CNB2004100480753A patent/CN100393873C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110643552A (zh) * | 2019-11-22 | 2020-01-03 | 河南省科学院生物研究所有限责任公司 | 一种利用可溶性淀粉制备海藻糖浆的菌株及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100393873C (zh) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112646793B (zh) | 低温适应性和盐适应性改良的菊粉酶突变体MutS120D及其应用 | |
CN112813051B (zh) | 热适应性改良的低温外切菊粉酶突变体MutP124G及应用 | |
CN112980813B (zh) | 低温改良的外切菊粉酶突变体MutS117G | |
CN112708607A (zh) | 热适应性改变的菊粉酶突变体MutS120R及其应用 | |
CN112980814B (zh) | 低温适应性提高的外切菊粉酶突变体MutV268Δ13 | |
CN112725309A (zh) | 一种中温下稳定的低温外切菊粉酶突变体MutP126R | |
CN110423737B (zh) | 来源于嗜热脂肪土芽孢杆菌的耐热型α-淀粉酶及其应用 | |
CN113430181B (zh) | 一种来源亚洲象肠道宏基因组的细菌漆酶及其基因 | |
CN1880460A (zh) | 大肠杆菌自裂解方法及其专用载体与应用 | |
CN1434861A (zh) | 克雷伯氏菌属的细菌分离物以及从其中分离的异麦芽酮糖合酶基因 | |
JP2015173602A (ja) | 酵素の自然変異体の取得方法及び超耐熱性セロビオハイドロラーゼ | |
CN1778928A (zh) | 一种转糖基α一半乳糖苷酶基因 | |
CN110184258B (zh) | 一种普鲁兰酶突变体 | |
CN1786170A (zh) | 一种高效转糖基β-半乳糖苷酶基因 | |
CN112301014B (zh) | 一种热稳定性提高的酯酶突变体及其应用 | |
CN1712525A (zh) | 淀粉海藻糖基合成酶及其编码基因与表达方法和工程菌 | |
Chauhan et al. | Mining of thermostable alpha-amylase gene from geothermal springs using a metagenomics approach | |
CN1223676C (zh) | 一种高温α-淀粉酶,及其编码基因 | |
CN110804620B (zh) | 一种麦芽糖生产用重组异淀粉酶高效表达及应用 | |
CN105062991B (zh) | 一类热稳定性提高的淀粉酶突变体及其编码基因和应用 | |
CN1313608C (zh) | 一种碱性α-淀粉酶及其编码基因与生产方法 | |
CN108913677B (zh) | 一种定点突变改造的碱性普鲁兰酶及其应用 | |
CN100347294C (zh) | 一种热稳定海藻糖合成酶及其编码基因与应用 | |
CN112646831A (zh) | 一种穿梭质粒及构建方法及其在集胞藻转化外源基因中的应用 | |
CN110616211A (zh) | 一种α-淀粉酶、编码基因、载体、宿主及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHENG HAN Free format text: FORMER OWNER: MICROBIOLOGY INST., CHINESE ACADEMY OF SCIENCES Effective date: 20120625 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100080 HAIDIAN, BEIJING TO: 100080 CHANGPING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120625 Address after: 100080 Beijing city Changping District town of Beiqijia Hongfu Industrial Park No. 10 hospital Patentee after: Zheng Han Address before: 100080 No. 13, north of Haidian District, Beijing, Zhongguancun Patentee before: Institute of Microbiology, Chinese Academy of Sciences |
|
DD01 | Delivery of document by public notice |
Addressee: Zheng Han Document name: Notification of Passing Examination on Formalities |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180129 Address after: 221000 Xuzhou province high tech Industrial Development Zone, Pearl River Road, No. office building, room 11, Room 606 Patentee after: WEIPU SECURITY TECHNOLOGY (XUZHOU) Co.,Ltd. Address before: 100080 Beijing city Changping District town of Beiqijia Hongfu Industrial Park No. 10 hospital Patentee before: Zheng Han |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20080611 |
|
CX01 | Expiry of patent term |